These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage. Scott R; Kersten B; Basior J; Nadler M J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892 [TBL] [Abstract][Full Text] [Related]
12. Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal. Zemrak W; Manuel F; Smith KE; Rolfe S; Hayes T; Trowbridge RL; Carlone B; Seder D J Thromb Thrombolysis; 2019 Feb; 47(2):263-271. PubMed ID: 30443817 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal. McMahon C; Halfpap J; Zhao Q; Bienvenida A; Rose AE Ann Pharmacother; 2021 Oct; 55(10):1230-1235. PubMed ID: 33522256 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study. Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592 [TBL] [Abstract][Full Text] [Related]
15. Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal. Gilbert BW; Morton L; Huffman JB; Roemer K; Potter A; Cassidy CD; Vasquez DG Am J Emerg Med; 2020 Apr; 38(4):806-809. PubMed ID: 31864879 [TBL] [Abstract][Full Text] [Related]
16. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage. Chu C; Tokumaru S; Izumi K; Nakagawa K Int J Neurosci; 2016; 126(1):62-6. PubMed ID: 25430740 [TBL] [Abstract][Full Text] [Related]
17. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal. Bajdas H; Handzel M; Uttaro E; Jones CMC; Kokanovich K; Acquisto NM Thromb Res; 2022 Jun; 214():76-81. PubMed ID: 35512560 [TBL] [Abstract][Full Text] [Related]
19. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage. Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162 [TBL] [Abstract][Full Text] [Related]
20. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding. Stewart WS; Pettit H Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]